hydroxycitric acid has been researched along with tamoxifen in 2 studies
Studies (hydroxycitric acid) | Trials (hydroxycitric acid) | Recent Studies (post-2010) (hydroxycitric acid) | Studies (tamoxifen) | Trials (tamoxifen) | Recent Studies (post-2010) (tamoxifen) |
---|---|---|---|---|---|
204 | 20 | 73 | 20,630 | 2,227 | 6,256 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Doghish, AS; E M Elsadek, B; Ismail, A; Mariee, AD; Salama, SA | 1 |
Attia, YM; Doghish, AS; Hassanein, SS; Ismail, A; Mariee, AD; Mokhlis, HA; Salama, SA; Sharaky, M; Sobhy, MH | 1 |
2 other study(ies) available for hydroxycitric acid and tamoxifen
Article | Year |
---|---|
Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; ATP Citrate (pro-S)-Lyase; Breast Neoplasms; Cell Proliferation; Cell Survival; Citrates; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; MCF-7 Cells; Molecular Structure; Structure-Activity Relationship; Tamoxifen | 2020 |
Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase.
Topics: ATP Citrate (pro-S)-Lyase; bcl-2-Associated X Protein; Caspase 3; Humans; Proto-Oncogene Proteins c-bcl-2; Tamoxifen | 2022 |